FDA
-
-
-
-
-
-
-
Dogwood Therapeutics files patent for synthetic Halneuron manufacturing
-
-
-
-
-
-
-
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
-
-
-
-
-
-
-
Dogwood Therapeutics (DWTX) Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain
-
-
-
-
-
-
-
Dogwood Therapeutics (DWTX) Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

